Inovio Pharmaceuticals, Inc.
INO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001055726
No open-market purchases or sales by Inovio Pharmaceuticals, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $36.1M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Inovio Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 135 | 2 | 127 | −6 |
| Shares | 71.7M | 14.7K | 55.5M | −16.2M (−22.6%) |
| Value | $32.1M | $6.58K | $21.6M | −$10.4M (−32.5%) |
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acadian Asset Management LLC | 460,200 | $178.0K | 0.00% |
| AQR Capital Management LLC | 449,706 | $174.9K | 0.00% |
| Gsa Capital Partners LLP | 296,948 | $116.0K | 0.01% |
| JustInvest LLC | 109,213 | $42.5K | 0.00% |
| Envestnet Asset Management Inc | 19,296 | $7.51K | 0.00% |
| Arkadios Wealth Advisors | 18,900 | $7.35K | 0.00% |
| GTS Securities LLC | 14,725 | $5.73K | 0.00% |
| Tiaa Trust, National Association | 14,348 | $5.58K | 0.00% |
| Means Investment Co., Inc. | 10,013 | $3.90K | 0.00% |
| PDS Planning, Inc | 10,000 | $3.89K | 0.00% |
| Cubist Systematic Strategies, LLC | 6,034 | $2.35K | 0.00% |
| Parallel Advisors, LLC | 1,280 | $498 | 0.00% |
| Householder Group Estate & Retirement Specialist, LLC | 1,274 | $495 | 0.00% |
| EverSource Wealth Advisors, LLC | 1,244 | $484 | 0.00% |
| Provence Wealth Management Group | 900 | $350 | 0.00% |
| Highlander Capital Management, LLC | 50 | $0 | 0.00% |
Sold out (22)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Y-Intercept (Hong Kong) Ltd | 633,613 | $282.9K |
| Point72 Middle East FZE | 500,624 | $223.5K |
| UBS Asset Management Americas Inc | 151,318 | $124.1K |
| Ergoteles LLC | 244,500 | $109.2K |
| CIBC Private Wealth Group, LLC | 119,110 | $53.2K |
| Laurion Capital Management LP | 115,925 | $51.8K |
| Schonfeld Strategic Advisors LLC | 107,687 | $48.1K |
| Old Mission Capital LLC | 105,927 | $47.3K |
| ExodusPoint Capital Management, LP | 75,792 | $34.0K |
| Allspring Global Investments Holdings, LLC | 66,536 | $29.7K |
| Barclays PLC | 64,715 | $28.9K |
| Centiva Capital, LP | 54,405 | $24.5K |
| Virtu Financial LLC | 47,902 | $21.0K |
| CTC Alternative Strategies, Ltd. | 22,000 | $9.82K |
| Squarepoint Ops LLC | 20,802 | $9.29K |
| Horan Securities, Inc. | 1,702 | $760 |
| New York State Common Retirement Fund | 1,626 | $726 |
| Compass Wealth Management LLC | 170 | $76 |
| Aspire Private Capital, LLC | 100 | $45 |
| ICA Group Wealth Management, LLC | 25 | $11 |
| Proequities, Inc. | 8 | $3 |
| Avion Wealth | 747 | $0 |
Not filed for Q3 2023 yet (2)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Tiaa, FSB | 14,383 | $6.42K |
| Kistler-Tiffany Companies, LLC | 365 | $163 |